| Renal Pelvis Carcinoma studied in …STUDIED_INderived38 of 38show fewer |
|---|
| → studied in | NCT05874921recruiting uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto · condition mapped ALIAS · 38 trials mapped (19 active) | — | — | Renal Pelvis Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05987241Phase 2/Phase 3 · recruiting Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study · condition mapped ONTOLOGY_EXACT · 38 trials mapped (19 active) | — | — | Muscle Invasive Renal Pelvis Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04963153Phase 1 · active not recruiting Testing Combination Erdafitinib and Enfortumab Vedotin in Metastatic Bladder Cancer After Treatment With Chemotherapy and Immunotherapy · condition mapped CURATED_BROADER · 38 trials mapped (19 active) | — | — | Renal Pelvis Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07667335Phase 1/Phase 2 · recruiting Enfortumab Vedotin, Pembrolizumab and Quemliclustat for the Treatment of Unresectable Locally Advanced and Metastatic Urothelial Cancer · condition mapped CURATED_BROADER · 38 trials mapped (19 active) | — | — | Renal Pelvis Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04940299Phase 2 · active not recruiting Tocilizumab, Ipilimumab, and Nivolumab for the Treatment of Advanced Melanoma, Non-Small Cell Lung Cancer, or Urothelial Carcinoma · condition mapped CURATED_BROADER · 38 trials mapped (19 active) | — | — | Renal Pelvis Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02812420early Phase 1 · active not recruiting Durvalumab and Tremelimumab in Treating Patients With Muscle-Invasive, High-Risk Urothelial Cancer That Cannot Be Treated With Cisplatin-Based Therapy Before Surgery · condition mapped CURATED_BROADER · 38 trials mapped (19 active) | — | — | Renal Pelvis Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05059444recruiting ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation · condition mapped ONTOLOGY_EXACT · 38 trials mapped (19 active) | — | — | Renal Pelvis Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02496208Phase 1 · active not recruiting Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors · condition mapped CURATED_BROADER · 38 trials mapped (19 active) | — | — | Renal Pelvis Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06465069Phase 1 · recruiting A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors · condition mapped ALIAS · 38 trials mapped (19 active) | — | — | Renal Pelvis Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06661720Phase 3 · recruiting Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer · condition mapped CURATED_BROADER · 38 trials mapped (19 active) | — | — | Renal Pelvis Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00902590active not recruiting A Genotype-Phenotype Urothelial Cancer Registry · condition mapped ALIAS · 38 trials mapped (19 active) | — | — | Renal Pelvis Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03237780Phase 2 · active not recruiting Atezolizumab With or Without Eribulin Mesylate in Treating Patients With Recurrent Locally Advanced or Metastatic Urothelial Cancer · condition mapped CURATED_BROADER · 38 trials mapped (19 active) | — | — | Renal Pelvis Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00942331Phase 3 · completed Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer · condition mapped CURATED_BROADER · 38 trials mapped (19 active) | — | — | Renal Pelvis Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05092958Phase 3 · active not recruiting Testing the Addition of the Anti-cancer Drug, Cabozantinib, to the Usual Immunotherapy Treatment, Avelumab, in Patients With Metastatic Urothelial Cancer, MAIN-CAV Study · condition mapped CURATED_BROADER · 38 trials mapped (19 active) | — | — | Renal Pelvis Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06238479Phase 1 · active not recruiting A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors · condition mapped ALIAS · 38 trials mapped (19 active) | — | — | Renal Pelvis Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04953104Phase 2 · active not recruiting ARID1A and/or KDM6A Mutation and CXCL13 Expression · condition mapped CURATED_BROADER · 38 trials mapped (19 active) | — | — | Renal Pelvis Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04637594Phase 3 · active not recruiting Trying to Find the Correct Length of Treatment With Immune Checkpoint Therapy · condition mapped CURATED_BROADER · 38 trials mapped (19 active) | — | — | Renal Pelvis Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04848519Phase 2 · active not recruiting Immune Checkpoint Inhibitors With or Without Propranolol Hydrochloride In Patients With Urothelial Carcinoma · condition mapped CURATED_BROADER · 38 trials mapped (19 active) | — | — | Renal Pelvis Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06652009recruiting Radical Radiotherapy Versus Radical Surgery for UTUC · condition mapped ALIAS · 38 trials mapped (19 active) | — | — | Renal Pelvis Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03513952Phase 2 · completed Atezolizumab and CYT107 in Treating Participants With Locally Advanced, Inoperable, or Metastatic Urothelial Carcinoma · condition mapped CURATED_BROADER · 38 trials mapped (19 active) | — | — | Renal Pelvis Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06469229not yet recruiting Performance Evaluation of Urine DNA Methylation Testing for the Detection of Urothelial Carcinoma in Patients With Hematuria · condition mapped ALIAS · 38 trials mapped (19 active) | — | — | Renal Pelvis Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06427993unknown Urine DNA Methylation Detection for Hematuria Evaluation · condition mapped ALIAS · 38 trials mapped (19 active) | — | — | Renal Pelvis Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04398368Phase 2 · terminated Gemcitabine for the Prevention of Intravesical Recurrence of Urothelial Cancer in Patients With Upper Urinary Tract Urothelial Cancer Undergoing Radical Nephroureterectomy, GEMINI Study · condition mapped CURATED_BROADER · 38 trials mapped (19 active) | — | — | Renal Pelvis Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05739812NA · unknown The Efficacy and Safety of Chinese Domestic Surgical Robot System in Urological Telesurgery · condition mapped ONTOLOGY_EXACT · 38 trials mapped (19 active) | — | — | Renal Pelvis Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03397394Phase 2 · terminated Rucaparib in Patients With Locally Advanced or Metastatic Urothelial Carcinoma · condition mapped ONTOLOGY_EXACT · 38 trials mapped (19 active) | — | — | Renal Pelvis Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03617913Phase 2 · completed Avelumab in Combination With Fluorouracil and Mitomycin or Cisplatin and Radiation Therapy in Treating Participants With Muscle-Invasive Bladder Cancer · condition mapped CURATED_BROADER · 38 trials mapped (19 active) | — | — | Renal Pelvis Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03662204completed Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors · condition mapped ALIAS · 38 trials mapped (19 active) | — | — | Renal Pelvis Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02793128Phase 3 · completed The OLYMPUS Study - Optimized DeLivery of Mitomycin for Primary UTUC Study · condition mapped ALIAS · 38 trials mapped (19 active) | — | — | Renal Pelvis Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00749892Phase 2 · completed Erlotinib Hydrochloride in Treating Participants With Muscle Invasive or Recurrent Urothelial Cancer · condition mapped CURATED_BROADER · 38 trials mapped (19 active) | — | — | Renal Pelvis Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03935347Phase 2 · withdrawn Adoptive Cell Therapy With (LN-145) in Combination With Pembrolizumab in Treating Patients With Unresectable or Metastatic Transitional Cell Cancer Who Have Failed Cisplatin-Based Chemotherapy · condition mapped CURATED_BROADER · 38 trials mapped (19 active) | — | — | Renal Pelvis Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02665039Phase 2 · completed A Trial With Vinflunine in Patients With Metastatic Bladder Cancer and Impaired Renal Function · condition mapped ALIAS · 38 trials mapped (19 active) | — | — | Renal Pelvis Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01282463Phase 2 · completed Study of Ramucirumab or Icrucumab (IMC-18F1) With Docetaxel or Docetaxel Alone as Second-Line Therapy in Participants With Bladder,Urethra, Ureter, or Renal Pelvis Carcinoma · condition mapped ALIAS · 38 trials mapped (19 active) | — | — | Renal Pelvis Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02300610Phase 1 · completed Enzalutamide in Combination With Gemcitabine and Cisplatin in Bladder Cancer · condition mapped ALIAS · 38 trials mapped (19 active) | — | — | Renal Pelvis Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01844947Phase 1 · completed Phase I Study With Sorafenib in Addition to Vinflunine in Metastatic Transitional Cell Carcinoma of the Urothelial Tract · condition mapped ALIAS · 38 trials mapped (19 active) | — | — | Renal Pelvis Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01236053completed Cancer in Patients With Gabapentin (GPRD) · condition mapped ALIAS · 38 trials mapped (19 active) | — | — | Renal Pelvis Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01138124completed Gabapentin and Risk of Pancreatic Cancer and Renal Cancer (GPRD) · condition mapped ALIAS · 38 trials mapped (19 active) | — | — | Renal Pelvis Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01182168Phase 1 · completed Gemcitabine and Split-Dose Cisplatin Plus Everolimus (RAD001) in Patients With Advanced Solid Tumor Malignancies · condition mapped ALIAS · 38 trials mapped (19 active) | — | — | Renal Pelvis Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00661609Phase 2 · completed A Phase II Study of AZD4877 (a Novel Anti-mitotic Agent) in Advanced Bladder Cancer · condition mapped ALIAS · 38 trials mapped (19 active) | — | — | Renal Pelvis Carcinoma | 1 | Observed | clinicaltrials | graph → |